BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6245448)

  • 1. Opiate analgesia: evidence for mediation by a subpopulation of opiate receptors.
    Pasternak GW; Childers SR; Snyder SH
    Science; 1980 May; 208(4443):514-6. PubMed ID: 6245448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxazone, a long-acting opiate antagonist: effects on analgesia in intact animals and on opiate receptor binding in vitro.
    Pasternak GW; Childers SR; Snyder SH
    J Pharmacol Exp Ther; 1980 Sep; 214(3):455-62. PubMed ID: 6105201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opiate, enkephalin, and endorphin analgesia: relations to a single subpopulation of opiate receptors.
    Pasternak GW
    Neurology; 1981 Oct; 31(10):1311-5. PubMed ID: 6287349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal and supraspinal opioid analgesia in the mouse: the role of subpopulations of opioid binding sites.
    Ling GS; Pasternak GW
    Brain Res; 1983 Jul; 271(1):152-6. PubMed ID: 6309332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxonazine, a potent, long-lasting inhibitor of opiate binding sites.
    Hahn EF; Pasternak GW
    Life Sci; 1982 Sep 20-27; 31(12-13):1385-8. PubMed ID: 6292633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different receptors mediate morphine-induced prolactin and growth hormone release.
    Spiegel K; Kourides IA; Pasternak GW
    Life Sci; 1982 Nov 15-22; 31(20-21):2177-80. PubMed ID: 6298516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of ethanol-induced conditioned taste aversion by naloxazone: behavioral evidence for an opiate receptor-mediated morphine-ethanol interaction.
    Ng Cheong Ton JM; Amit Z
    Neurosci Lett; 1984 Jul; 48(2):127-32. PubMed ID: 6090995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple opiate receptors: [3H]ethylketocyclazocine receptor binding and ketocyclazocine analgesia.
    Pasternak GW
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3691-4. PubMed ID: 6251477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxazone lacks therapeutic effects in endotoxic shock yet blocks the effects of naloxone.
    Holaday JW; Pasternak GW; D'Amato RJ; Ruvio BA; Faden AI
    Eur J Pharmacol; 1983 May; 89(3-4):293-6. PubMed ID: 6307712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine catalepsy in the rat: involvement of mu 1 (high affinity) opioid binding sites.
    Ling GS; Pasternak GW
    Neurosci Lett; 1982 Oct; 32(2):193-6. PubMed ID: 6292799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxonazine actions in vivo.
    Ling GS; Simantov R; Clark JA; Pasternak GW
    Eur J Pharmacol; 1986 Sep; 129(1-2):33-8. PubMed ID: 3021478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxazone pretreatment modifies cardiorespiratory, temperature, and behavioral effects of morphine.
    Holaday JW; Pasternak GW; Faden AI
    Neurosci Lett; 1983 Jun; 37(2):199-204. PubMed ID: 6308526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin and growth hormone release by morphine in the rat: different receptor mechanisms.
    Spiegel K; Kourides IA; Pasternak GW
    Science; 1982 Aug; 217(4561):745-7. PubMed ID: 6285470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxazone and pain-inhibitory systems: evidence for a collateral inhibition model.
    Kirchgessner AL; Bodnar RJ; Pasternak GW
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1175-9. PubMed ID: 7163350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible opiate agonists and antagonists: the 14-hydroxydihydromorphinone azines.
    Hahn EF; Carroll-Buatti M; Pasternak GW
    J Neurosci; 1982 May; 2(5):572-6. PubMed ID: 6176696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-acting opiate agonists and antagonists: 14-hydroxydihydromorphinone hydrazones.
    Pasternak GW; Hahn EF
    J Med Chem; 1980 Jun; 23(6):674-6. PubMed ID: 6156240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical analgesia produced by low doses of the opiate-antagonist naloxone is mediated by interaction at a site with characteristics of the delta opioid receptor.
    Taiwo YO; Basbaum AI; Perry F; Levine JD
    J Pharmacol Exp Ther; 1989 Apr; 249(1):97-100. PubMed ID: 2540325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different opioid systems may participate in post-electro-convulsive shock (ECS) analgesia and catalepsy.
    Urca G; Yitzhaky J; Frenk H
    Brain Res; 1981 Aug; 219(2):385-96. PubMed ID: 6266608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An increase in opiate receptor-sites is associated with enhanced cardiovascular depressant, but not respiratory depressant action of morphine.
    Pfeiffer A; Pfeiffer DG; Feuerstein G; Faden AI; Kopin IJ
    Brain Res; 1984 Apr; 296(2):305-11. PubMed ID: 6322927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphine exacerbates anaphylactic shock in mice by stimulating central opiate receptors.
    Amir S
    Neurosci Lett; 1983 Sep; 40(2):169-74. PubMed ID: 6314208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.